Altimmune, Inc. (ALT)
2.625
-0.04
(-1.32%)
USD |
NASDAQ |
Jun 10, 14:41
Altimmune SG&A Expense (Quarterly) : 8.052M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 6.86M |
| Amgen, Inc. | 1.602B |
| Halozyme Therapeutics, Inc. | 57.88M |
| Protalix Biotherapeutics, Inc. | 3.051M |
| Humacyte, Inc. | 7.93M |